[1]
Zhang, Q.; Zhao, N.; Meng, X.; Yu, F.; Yao, X.; Liu, H. The prediction of protein–ligand unbinding for modern drug discovery. Expert Opin. Drug Discov., 2022, 17(2), 191-205.
[http://dx.doi.org/ 10.1080/17460441.2022.2002298]
[http://dx.doi.org/ 10.1080/17460441.2022.2002298]
[2]
Guo, J.; Zhou, H-X. Protein allostery and conformational dynamics. Chem. Rev., 2016, 116, 6503-6515.
[http://dx.doi.org/10.1021/acs.chemrev.5b00590]
[http://dx.doi.org/10.1021/acs.chemrev.5b00590]
[3]
Klepeis, J.L.; Lindorff-Larsen, K.; Dror, R.O.; Shaw, D.E. Long-timescale molecular dynamics simulations of protein structure and function. Curr. Opin. Struct. Biol., 2009, 19, 120-127.
[http://dx.doi.org/10.1016/j.sbi.2009.03.004]
[http://dx.doi.org/10.1016/j.sbi.2009.03.004]
[4]
Naqvi, A.A.T.; Mohammad, T.; Hasan, G.M.; Hassan, M.I. Advancements in docking and molecular dynamics simulations towards ligand-receptor interactions and structure-function relationships. Curr. Topics Med. Chem., 2018, 18, 1755-1768.
[http://dx.doi.org/10.2174/1568026618666181025114157]
[http://dx.doi.org/10.2174/1568026618666181025114157]
[5]
Li, M.; Bao, Y.; Li, M.; Guo, J. GPCR allostery: A view from computational biology. Curr. Med. Chem., 2023, 30, 4533-4553.
[http://dx.doi.org/10.2174/0929867330666230113125246]
[http://dx.doi.org/10.2174/0929867330666230113125246]
[6]
Aci-Sèche, S.; Ziada, S.; Braka, A.; Arora, R.; Bonnet, P. Advanced molecular dynamics simulation methods for kinase drug discovery. Fut. Med. Chem., 2016, 8, 545-566.
[http://dx.doi.org/10.4155/fmc.16.9]
[http://dx.doi.org/10.4155/fmc.16.9]
[7]
Wang, L.; Zhang, Q.; Tong, H.H.Y.; Yao, X.; Liu, H.; Li, G. Computational methods for unlocking the secrets of potassium channels: Structure, mechanism, and drug design. Wiley Interdisciplinary Reviews: Comp. Mol. Sci., 2024, 14(1), e1704.
[http://dx.doi.org/10.1002/wcms.1704]
[http://dx.doi.org/10.1002/wcms.1704]
[8]
Barredo, P.A.; Balanay, M.P. Recent advances in molecular dynamics simulations of tau fibrils and oligomers. Membranes, 2023, 13.
[http://dx.doi.org/10.3390/membranes13030277]
[http://dx.doi.org/10.3390/membranes13030277]
[9]
Xu, B.; Chen, Y.; Xue, W. Computational protein design - where it goes? Curr. Med. Chem., 2024, 31(20), 2841-2854.
[http://dx.doi.org/10.2174/0929867330666230602143700]
[http://dx.doi.org/10.2174/0929867330666230602143700]
[10]
Zhong, H.; Liu, H.; Liu, H. Molecular mechanism of tau misfolding and aggregation: Insights from molecular dynamics simulation. Curr. Med. Chem., 2024, 31(20), 2855-2871.
[http://dx.doi.org/10.2174/0929867330666230409145247]
[http://dx.doi.org/10.2174/0929867330666230409145247]
[11]
Shah, S.J.A.; Zhang, Q.; Guo, J.; Liu, H.; Liu, H.; Villà-Freixa, J. Identification of aggregation mechanism of acetylated PHF6* and PHF6 tau peptides based on molecular dynamics simulations and markov state modeling. ACS Chem. Neurosci., 2023, 14, 3959-3971.
[http://dx.doi.org/10.1021/acschemneuro.3c00578]
[http://dx.doi.org/10.1021/acschemneuro.3c00578]
[12]
Su, J.; Fu, C.; Wang, S.; Chen, X.; Wang, R.; Shi, H.; Li, J.; Wang, X. Screening and activity evaluation of novel BCR-ABL/T315I tyrosine kinase inhibitors. Curr. Med. Chem., 2024, 31(20), 2872-2894.
[http://dx.doi.org/10.2174/0929867330666230519105900]
[http://dx.doi.org/10.2174/0929867330666230519105900]
Related Journals
Current Pharmaceutical Design
Current Topics in Medicinal Chemistry
Current Respiratory Medicine Reviews
Infectious Disorders - Drug Targets
Endocrine, Metabolic & Immune Disorders - Drug Targets
Anti-Infective Agents
Coronaviruses
Recent Advances in Inflammation & Allergy Drug Discovery
Current Probiotics
